1887
  1. Home
  2. Eurosurveillance
  3. Volume 24, Issue 20, 16/May/2019
  4. Article
Research Open Access
Like 1
This item has no PDF Download

Abstract

Background

To control respiratory syncytial virus (RSV), which causes acute respiratory infections, data and methods to assess its epidemiology are important.

Aim

We sought to describe RSV seasonality, affected age groups and RSV-type distribution over 12 consecutive seasons in the Netherlands, as well as to validate the moving epidemic method (MEM) for monitoring RSV epidemics.

Methods

We used 2005−17 laboratory surveillance data and sentinel data. For RSV seasonality evaluation, epidemic thresholds (i) at 1.2% of the cumulative number of RSV-positive patients per season and (ii) at 20 detections per week (for laboratory data) were employed. We also assessed MEM thresholds.

Results

In laboratory data RSV was reported 25,491 times (no denominator). In sentinel data 5.6% (767/13,577) of specimens tested RSV positive. Over 12 seasons, sentinel data showed percentage increases of RSV positive samples. The average epidemic length was 18.0 weeks (95% confidence intervals (CI):  16.3–19.7) and 16.5 weeks (95% CI: 14.0–18.0) for laboratory and sentinel data, respectively. Epidemics started on average in week 46 (95% CI: 45–48) and 47 (95% CI:  46–49), respectively. The peak was on average in the first week of January in both datasets. MEM showed similar results to the other methods. RSV incidence was highest in youngest (0–1 and >1–2 years) and oldest (>65–75 and > 75 years) age groups, with age distribution remaining stable over time. RSV-type dominance alternated every one or two seasons.

Conclusions

Our findings provide baseline information for immunisation advisory groups. The possibility of employing MEM to monitor RSV epidemics allows prospective, nearly real-time use of surveillance data.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2019.24.20.1800469
2019-05-16
2024-04-16
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2019.24.20.1800469
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/24/20/eurosurv-24-20-5.html?itemId=/content/10.2807/1560-7917.ES.2019.24.20.1800469&mimeType=html&fmt=ahah

References

  1. Chalker VJ, Stocki T, Mentasti M, Fleming D, Sadler C, Ellis J, et al. Mycoplasma pneumoniae infection in primary care investigated by real-time PCR in England and Wales. Eur J Clin Microbiol Infect Dis. 2011;30(7):915-21.  https://doi.org/10.1007/s10096-011-1176-3  PMID: 21311941 
  2. Robinson RF. Impact of respiratory syncytial virus in the United States. Am J Health Syst Pharm. 2008;65(23) Suppl 8;S3-6.  https://doi.org/10.2146/ajhp080438  PMID: 19020201 
  3. Bont L, Checchia PA, Fauroux B, Figueras-Aloy J, Manzoni P, Paes B, et al. Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries. Infect Dis Ther. 2016;5(3):271-98.  https://doi.org/10.1007/s40121-016-0123-0  PMID: 27480325 
  4. Shi T, McAllister DA, O’Brien KL, Simoes EAF, Madhi SA, Gessner BD, et al. RSV Global Epidemiology Network. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017;390(10098):946-58.  https://doi.org/10.1016/S0140-6736(17)30938-8  PMID: 28689664 
  5. van Asten L, van den Wijngaard C, van Pelt W, van de Kassteele J, Meijer A, van der Hoek W, et al. Mortality attributable to 9 common infections: significant effect of influenza A, respiratory syncytial virus, influenza B, norovirus, and parainfluenza in elderly persons. J Infect Dis. 2012;206(5):628-39.  https://doi.org/10.1093/infdis/jis415  PMID: 22723641 
  6. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005;352(17):1749-59.  https://doi.org/10.1056/NEJMoa043951  PMID: 15858184 
  7. Campbell H, Bont L, Nair H. Respiratory syncytial virus (RSV) disease - new data needed to guide future policy. J Glob Health. 2015;5(2):020101.  https://doi.org/10.7189/jogh.05.020101  PMID: 26755941 
  8. Chatzis O, Darbre S, Pasquier J, Meylan P, Manuel O, Aubert JD, et al. Burden of severe RSV disease among immunocompromised children and adults: a 10 year retrospective study. BMC Infect Dis. 2018;18(1):111.  https://doi.org/10.1186/s12879-018-3002-3  PMID: 29510663 
  9. Manzoni P, Figueras-Aloy J, Simões EAF, Checchia PA, Fauroux B, Bont L, et al. Defining the Incidence and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Children with Chronic Diseases. Infect Dis Ther. 2017;6(3):383-411.  https://doi.org/10.1007/s40121-017-0160-3  PMID: 28653300 
  10. Volling C, Hassan K, Mazzulli T, Green K, Al-Den A, Hunter P, et al. Respiratory syncytial virus infection-associated hospitalization in adults: a retrospective cohort study. BMC Infect Dis. 2014;14(1):665.  https://doi.org/10.1186/s12879-014-0665-2  PMID: 25494918 
  11. Kyeyagalire R, Tempia S, Cohen AL, Smith AD, McAnerney JM, Dermaux-Msimang V, et al. Hospitalizations associated with influenza and respiratory syncytial virus among patients attending a network of private hospitals in South Africa, 2007-2012. BMC Infect Dis. 2014;14(1):694.  https://doi.org/10.1186/s12879-014-0694-x  PMID: 25510622 
  12. Meerhoff TJ, Mosnier A, Schellevis F, Paget WJEISS RSV Task Group. Progress in the surveillance of respiratory syncytial virus (RSV) in Europe: 2001-2008. Euro Surveill. 2009;14(40):1-5. PMID: 19822120 
  13. Paget WJ, Balderston C, Casas I, Donker G, Edelman L, Fleming D, et al. EPIA collaborators. Assessing the burden of paediatric influenza in Europe: the European Paediatric Influenza Analysis (EPIA) project. Eur J Pediatr. 2010;169(8):997-1008.  https://doi.org/10.1007/s00431-010-1164-0  PMID: 20229049 
  14. Broberg EK, Waris M, Johansen K, Snacken R, Penttinen PEuropean Influenza Surveillance Network. Seasonality and geographical spread of respiratory syncytial virus epidemics in 15 European countries, 2010 to 2016. Euro Surveill. 2018;23(5):1-11.  https://doi.org/10.2807/1560-7917.ES.2018.23.5.17-00284  PMID: 29409569 
  15. Meerhoff TJ, Paget JW, Kimpen JL, Schellevis F. Variation of respiratory syncytial virus and the relation with meteorological factors in different winter seasons. Pediatr Infect Dis J. 2009;28(10):860-6.  https://doi.org/10.1097/INF.0b013e3181a3e949  PMID: 20118684 
  16. van Asten L, Bijkerk P, Fanoy E, van Ginkel A, Suijkerbuijk A, van der Hoek W, et al. Early occurrence of influenza A epidemics coincided with changes in occurrence of other respiratory virus infections. Influenza Other Respir Viruses. 2016;10(1):14-26.  https://doi.org/10.1111/irv.12348  PMID: 26369646 
  17. Bloom-Feshbach K, Alonso WJ, Charu V, Tamerius J, Simonsen L, Miller MA, et al. Latitudinal variations in seasonal activity of influenza and respiratory syncytial virus (RSV): a global comparative review. PLoS One. 2013;8(2):e54445.  https://doi.org/10.1371/journal.pone.0054445  PMID: 23457451 
  18. Obando-Pacheco P, Justicia-Grande AJ, Rivero-Calle I, Rodríguez-Tenreiro C, Sly P, Ramilo O, et al. Respiratory Syncytial Virus Seasonality: A Global Overview. J Infect Dis. 2018;217(9):1356-64.  https://doi.org/10.1093/infdis/jiy056  PMID: 29390105 
  19. Vega T, Lozano JE, Meerhoff T, Snacken R, Mott J, Ortiz de Lejarazu R, et al. Influenza surveillance in Europe: establishing epidemic thresholds by the moving epidemic method. Influenza Other Respir Viruses. 2013;7(4):546-58.  https://doi.org/10.1111/j.1750-2659.2012.00422.x  PMID: 22897919 
  20. Murray JLK, Marques DFP, Cameron RL, Potts A, Bishop J, von Wissmann B, et al. Moving epidemic method (MEM) applied to virology data as a novel real time tool to predict peak in seasonal influenza healthcare utilisation. The Scottish experience of the 2017/18 season to date. Euro Surveill. 2018;23(11):23.  https://doi.org/10.2807/1560-7917.ES.2018.23.11.18-00079  PMID: 29560854 
  21. Bijkerk P, de Gier B, Nijsten DRE, Duijster JW, Soetens LC, Hahné SJM, et al. State of Infectious Diseases in the Netherlands. RIVM Report. Bilthoven: RIVM; 2016. 0069.
  22. Kapsenberg JG. Jaaroverzicht 1979 van het diagnostische en epidemiologische virusonderzoek in Nederland. [Annual 1979 survey of diagnostic and epidemiologic virus studies in the Netherlands]. Ned Tijdschr Geneeskd. 1981;125(12):485-8. PMID: 7219586 
  23. van den Brandhof WE, Kroes ACM, Bosman A, Peeters MF, Heijnen M. Rapportage van virologische diagnostiek in Nederland; representativiteit van de gegevens uit de virologische weekstaten. Infect Bull.2002;13:137-43.
  24. Donker G. NIVEL Zorgregistraties eerste lijn - Peilstations 2017. Utrecht: NIVEL; 2018.
  25. Teirlinck AC, Van Asten L, Brandsema PS, Dijkstra F, Donker GA, Van Gageldonk-Lafeber AB, et al. Annual report Surveillance of Influenza and other respiratory infections in the Netherlands: winter 2016/2017. RIVM Report. Bilthoven: RIVM; 2017.
  26. Walsh EE, Peterson DR, Kalkanoglu AE, Lee FE-H, Falsey AR. Viral shedding and immune responses to respiratory syncytial virus infection in older adults. J Infect Dis. 2013;207(9):1424-32.  https://doi.org/10.1093/infdis/jit038  PMID: 23382572 
  27. Wathuo M, Medley GF, Nokes DJ, Munywoki PK. Quantification and determinants of the amount of respiratory syncytial virus (RSV) shed using real time PCR data from a longitudinal household study. Wellcome Open Res. 2016;1(27):27.  https://doi.org/10.12688/wellcomeopenres.10284.1  PMID: 28066826 
  28. Vega T, Lozano JE, Meerhoff T, Snacken R, Beauté J, Jorgensen P, et al. Influenza surveillance in Europe: comparing intensity levels calculated using the moving epidemic method. Influenza Other Respir Viruses. 2015;9(5):234-46.  https://doi.org/10.1111/irv.12330  PMID: 26031655 
  29. Lozano JE. Second release of the MEM Shiny Web Application R package. 2018.
  30. Lozano JE., Bergström J, Carnahan A VT. The Moving Epidemic Method. The MEM Web Application: technical manual. 2018.
  31. Meijer A, Brown C, Hungnes O, Schweiger B, Valette M, van der Werf S, et al. Virology Task Groups of the European Influenza Surveillance Scheme. Programme of the Community Network of Reference Laboratories for Human Influenza to improve Influenza Surveillance in Europe. Vaccine. 2006;24(44-46):6717-23.  https://doi.org/10.1016/j.vaccine.2006.05.068  PMID: 16782242 
  32. van den Berg MJ, Cardol M, Bongers FJM, de Bakker DH. Changing patterns of home visiting in general practice: an analysis of electronic medical records. BMC Fam Pract. 2006;7(1):58.  https://doi.org/10.1186/1471-2296-7-58  PMID: 17044914 
  33. Zambon MC, Stockton JD, Clewley JP, Fleming DM. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet. 2001;358(9291):1410-6.  https://doi.org/10.1016/S0140-6736(01)06528-X  PMID: 11705487 
  34. Widmer K, Zhu Y, Williams JV, Griffin MR, Edwards KM, Talbot HK. Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. J Infect Dis. 2012;206(1):56-62.  https://doi.org/10.1093/infdis/jis309  PMID: 22529314 
  35. Meijer A, Overduin P, Hommel D, van Rijnsoever-Greven Y, Haenen A, Veldman-Ariesen MJ. Outbreak of respiratory syncytial virus infections in a nursing home and possible sources of introduction: the Netherlands, winter 2012/2013. J Am Geriatr Soc. 2013;61(12):2230-1.  https://doi.org/10.1111/jgs.12565  PMID: 24329823 
  36. Griffiths C, Drews SJ, Marchant DJ. Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment. Clin Microbiol Rev. 2017;30(1):277-319.  https://doi.org/10.1128/CMR.00010-16  PMID: 27903593 
  37. White LJ, Waris M, Cane PA, Nokes DJ, Medley GF. The transmission dynamics of groups A and B human respiratory syncytial virus (hRSV) in England & Wales and Finland: seasonality and cross-protection. Epidemiol Infect. 2005;133(2):279-89.  https://doi.org/10.1017/S0950268804003450  PMID: 15816153 
  38. Modjarrad K, Giersing B, Kaslow DC, Smith PG, Moorthy VSWHO RSV Vaccine Consultation Expert Group. WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015. Vaccine. 2016;34(2):190-7.  https://doi.org/10.1016/j.vaccine.2015.05.093  PMID: 26100926 
  39. Vandini S, Biagi C, Lanari M. Respiratory Syncytial Virus: The Influence of Serotype and Genotype Variability on Clinical Course of Infection. Int J Mol Sci. 2017;18(8):1717.  https://doi.org/10.3390/ijms18081717  PMID: 28783078 
  40. Jounai N, Yoshioka M, Tozuka M, Inoue K, Oka T, Miyaji K, et al. Age-Specific Profiles of Antibody Responses against Respiratory Syncytial Virus Infection. EBioMedicine. 2017;16:124-35.  https://doi.org/10.1016/j.ebiom.2017.01.014  PMID: 28111238 
  41. Vega Alonso T, Lozano Alonso JE, Ortiz de Lejarazu R, Gutiérrez Pérez M. Modelling influenza epidemic—can we detect the beginning and predict the intensity and duration? Int Congr Ser. 2004;1263:281-3.  https://doi.org/10.1016/j.ics.2004.02.121 
Use of the moving epidemic method (MEM) to assess national surveillance data for respiratory syncytial virus (RSV) in the Netherlands, 2005 to 2017
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Laura+M+Vos&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Vos Laura M</a>, <a href="/search?value1=Anne+C+Teirlinck&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Teirlinck Anne C</a>, <a href="/search?value1=Jos%C3%A9+E+Lozano&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Lozano José E</a>, <a href="/search?value1=Tom%C3%A1s+Vega&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Vega Tomás</a>, <a href="/search?value1=G%C3%A9+A+Donker&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Donker Gé A</a>, <a href="/search?value1=Andy+IM+Hoepelman&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Hoepelman Andy IM</a>, <a href="/search?value1=Louis+J+Bont&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Bont Louis J</a>, <a href="/search?value1=Jan+Jelrik+Oosterheert&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Oosterheert Jan Jelrik</a>, <a href="/search?value1=Adam+Meijer&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Meijer Adam</a></span>. Use of the moving epidemic method (MEM) to assess national surveillance data for respiratory syncytial virus (RSV) in the Netherlands, 2005 to 2017. <a href="/content/ecdc">Euro Surveill.</a> 2019;24(20):pii=1800469. <a href="https://doi.org/10.2807/1560-7917.ES.2019.24.20.1800469" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2019.24.20.1800469</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 22 Aug 2018;&nbsp;&nbsp; <span class="generated">Accepted</span>: 18 Feb 2019 </span> </p>
/content/10.2807/1560-7917.ES.2019.24.20.1800469
/content/10.2807/1560-7917.ES.2019.24.20.1800469
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error